The rapid development of techniques available for fetal examination an
d tissue sampling, coupled with novel methods for enzymological, cytog
enetic and DNA analysis has enabled the intrauterine detection of feta
l skin disorders to become an integral part of the management of sever
al genetic skin diseases. The relevance of new prenatal diagnostic met
hods to genetic diseases with major cutaneous manifestations is still
largely limited to the detection of structural abnormalities in fetal
skin biopsies (epidermolysis bullosa, keratinization disorders, pigmen
tation disorders). But the enormous advances in molecular biology of t
he epidermolysis bullosa group and the epidermolytic hyperkeratosis wi
ll soon allow identification of affected fetuses and possibly carriers
.